Christine (Chris) Fox, VP and general manager UK and Ireland at Amgen, two months into her first country manager position and first time in a role outside of North America, discusses the creation of new, innovative partnership models with stakeholders across the healthcare spectrum, how Amgen is leveraging its biologic manufacturing expertise to move into biosimilars, and the importance of the UK’s exceptional science and talent base.
What makes managing our joint affiliate work from an Amgen perspective is the cross-functional teamwork and the fact that the same portfolio is represented in both markets, although Ireland is in a different stage of its journey
